FDA Inspection
Chartwell Pharmaceuticals Amityville, LLCChartwell Pharmaceuticals Amityville, LLC – FDA Inspection, Dec 13, 2012
Record Details
This FDA Inspection record concerns Chartwell Pharmaceuticals Amityville, LLC, with an inspection on December 13, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 13, 2012
- Product Type
- Drugs
View Company Profile
ID · e1f3ad7d-123e-4687-abf5-058952c953ed
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 810835
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Chartwell Pharmaceuticals Amityville, LLC
13| Date | Classification | Office | Project area |
|---|---|---|---|
| December 21, 2022 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| February 13, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 20, 2017 | Not classified | New York District Office | |
| May 5, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 15, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chartwell Pharmaceuticals Amityville, LLC
- FDA Inspection 1193806 - 2022-12-21
- FDA Inspection 1079804 - 2019-02-13
- FDA Inspection 1020105 - 2017-07-20
- FDA Inspection 1011507 - 2017-05-05
- FDA Inspection 980564 - 2016-07-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.